Aetheramides A and B, potent HIV-inhibitory depsipeptides from a myxobacterium of the new genus "Aetherobacter"

Org Lett. 2012 Jun 1;14(11):2854-7. doi: 10.1021/ol3011002. Epub 2012 May 22.

Abstract

Aetheramides are structurally distinctive cyclic peptides isolated from a novel myxobacterial genus proposed to be termed "Aetherobacter". The structures were solved by a combination of NMR analyses, quantum mechanical calculations, and chemical derivatizations. Aetheramides which contain a unique polyketide moiety and two amino acid residues potently inhibited HIV-1 infection with IC(50) values of ~0.015 μM. Furthermore aetheramides showed cytostatic activity against human colon carcinoma (HCT-116) cells with IC(50) values of 0.11 μM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / chemistry
  • Anti-HIV Agents / isolation & purification*
  • Anti-HIV Agents / pharmacology*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / pharmacology*
  • Depsipeptides / chemistry
  • Depsipeptides / isolation & purification*
  • Depsipeptides / pharmacology*
  • Drug Screening Assays, Antitumor
  • HCT116 Cells
  • HIV-1 / drug effects*
  • Humans
  • Molecular Structure
  • Myxococcales / chemistry*
  • Nuclear Magnetic Resonance, Biomolecular

Substances

  • Anti-HIV Agents
  • Antineoplastic Agents
  • Depsipeptides
  • aetheramide A
  • aetheramide B